Cargando…
Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
BACKGROUND: Preoperative PSA, ISUP grade group (GG), prostate examination and multiparametric MRI (mpMRI) form the basis of prostate cancer staging. Unlike other solid organ tumours, tumour volume (TV) is not routinely used aside from crude estimates such as maximum cancer core length. The aim of th...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247356/ https://www.ncbi.nlm.nih.gov/pubmed/34845306 http://dx.doi.org/10.1038/s41391-021-00468-4 |
_version_ | 1785055182893088768 |
---|---|
author | Raison, Nicholas Servian, Pol Patel, Amit Santhirasekaram, Ainkaran Smith, Andrew Yeung, Maidie Lloyd, Josephine Mannion, Ethna Rockall, Andrea Ahmed, Hashim Winkler, Mathias |
author_facet | Raison, Nicholas Servian, Pol Patel, Amit Santhirasekaram, Ainkaran Smith, Andrew Yeung, Maidie Lloyd, Josephine Mannion, Ethna Rockall, Andrea Ahmed, Hashim Winkler, Mathias |
author_sort | Raison, Nicholas |
collection | PubMed |
description | BACKGROUND: Preoperative PSA, ISUP grade group (GG), prostate examination and multiparametric MRI (mpMRI) form the basis of prostate cancer staging. Unlike other solid organ tumours, tumour volume (TV) is not routinely used aside from crude estimates such as maximum cancer core length. The aim of this study is to assess the role of TV as a marker for oncological outcomes in high-risk non-metastatic prostate cancer. METHODS: A prospectively maintained database of patients undergoing minimally invasive (laparoscopic or robot-assisted laparoscopic) radical prostatectomy at a UK centre between 2007 and 2019 were analysed. A total of 251 patients with NCCN high or very high-risk prostate cancer were identified. Primary outcome measure was time to biochemical recurrence (BCR) and the secondary outcome was time to treatment failure (TTF). TV was measured on the pathological specimen using the stacking method. Multivariable cox regression analysis was used to identify factors predicting BCR and TFF. TV as a predictor of BCR and TFF was further analysed through time-dependent receiver operating characteristic (ROC) curves. Kaplan–Meier survival estimates were used to evaluate TV cut-off scores. RESULTS: Median follow up was 4.50 years. Four factors were associated with BCR and TFF on multivariable analysis (TV, pathological GG, pathological T stage, positive margin >3 mm). Area under the Curve (AUC) for TV as a predictor of BCR and TTF at 5 years was 0.71 and 0.75, respectively. Including all 4 variables in the model increased AUC to 0.84 and 0.85 for BCR and TFF. A 2.50 cm TV cut off demonstrated a significance difference in time to BCR, p < 0.001. CONCLUSIONS: Pathological tumour volume is an independent predictor of oncological outcomes in high risk prostate cancer but does not add significant prognostic value when combined with established variables. However, the option of accurate TV measurement on mpMRI raises the possibility of using TV as useful marker for preoperative risk stratification. |
format | Online Article Text |
id | pubmed-10247356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102473562023-06-09 Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? Raison, Nicholas Servian, Pol Patel, Amit Santhirasekaram, Ainkaran Smith, Andrew Yeung, Maidie Lloyd, Josephine Mannion, Ethna Rockall, Andrea Ahmed, Hashim Winkler, Mathias Prostate Cancer Prostatic Dis Article BACKGROUND: Preoperative PSA, ISUP grade group (GG), prostate examination and multiparametric MRI (mpMRI) form the basis of prostate cancer staging. Unlike other solid organ tumours, tumour volume (TV) is not routinely used aside from crude estimates such as maximum cancer core length. The aim of this study is to assess the role of TV as a marker for oncological outcomes in high-risk non-metastatic prostate cancer. METHODS: A prospectively maintained database of patients undergoing minimally invasive (laparoscopic or robot-assisted laparoscopic) radical prostatectomy at a UK centre between 2007 and 2019 were analysed. A total of 251 patients with NCCN high or very high-risk prostate cancer were identified. Primary outcome measure was time to biochemical recurrence (BCR) and the secondary outcome was time to treatment failure (TTF). TV was measured on the pathological specimen using the stacking method. Multivariable cox regression analysis was used to identify factors predicting BCR and TFF. TV as a predictor of BCR and TFF was further analysed through time-dependent receiver operating characteristic (ROC) curves. Kaplan–Meier survival estimates were used to evaluate TV cut-off scores. RESULTS: Median follow up was 4.50 years. Four factors were associated with BCR and TFF on multivariable analysis (TV, pathological GG, pathological T stage, positive margin >3 mm). Area under the Curve (AUC) for TV as a predictor of BCR and TTF at 5 years was 0.71 and 0.75, respectively. Including all 4 variables in the model increased AUC to 0.84 and 0.85 for BCR and TFF. A 2.50 cm TV cut off demonstrated a significance difference in time to BCR, p < 0.001. CONCLUSIONS: Pathological tumour volume is an independent predictor of oncological outcomes in high risk prostate cancer but does not add significant prognostic value when combined with established variables. However, the option of accurate TV measurement on mpMRI raises the possibility of using TV as useful marker for preoperative risk stratification. Nature Publishing Group UK 2021-11-29 2023 /pmc/articles/PMC10247356/ /pubmed/34845306 http://dx.doi.org/10.1038/s41391-021-00468-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Raison, Nicholas Servian, Pol Patel, Amit Santhirasekaram, Ainkaran Smith, Andrew Yeung, Maidie Lloyd, Josephine Mannion, Ethna Rockall, Andrea Ahmed, Hashim Winkler, Mathias Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? |
title | Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? |
title_full | Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? |
title_fullStr | Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? |
title_full_unstemmed | Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? |
title_short | Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? |
title_sort | is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247356/ https://www.ncbi.nlm.nih.gov/pubmed/34845306 http://dx.doi.org/10.1038/s41391-021-00468-4 |
work_keys_str_mv | AT raisonnicholas istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT servianpol istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT patelamit istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT santhirasekaramainkaran istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT smithandrew istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT yeungmaidie istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT lloydjosephine istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT mannionethna istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT rockallandrea istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT ahmedhashim istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer AT winklermathias istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer |